MTA Ancillary Agreement: Michigan-IRE1

Please consult the UBMTA for definitions of ORIGINAL MATERIAL and
RECIPIENT regarding this transfer of the ORIGINAL MATERIAL.

By agreeing to this ancillary agreement, the RECIPIENT agrees to the
following:

The ORIGINAL MATERIAL contains IRE1 cDNA (IRE1), which is the property
of the Regents of The University of Michigan and the Howard Hughes
Medical Institute (IRE1 PROVIDER).

The RECIPIENT understands that IRE1 in ORIGINAL MATERIAL is
experimental in nature and may have hazardous properties. The IRE1
PROVIDER MAKES NO REPRESENTATIONS AND EXTENDS NO WARRANTIES OF ANY
KIND, EITHER EXPRESSED OR IMPLIED. THERE ARE NO EXPRESS OR IMPLIED
WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR
THAT THE USE OF IRE1 WILL NOT INFRINGE ANY PATENT, COPYRIGHT,
TRADEMARK, OR OTHER PROPRIETARY RIGHTS.

Except to the extent prohibited by law, the RECIPIENT assumes all
liability for damages which may arise from its use, storage or
disposal of IRE1. The IRE1 PROVIDER will not be liable to the
RECIPIENT for any loss, claim or demand made by the RECIPIENT, or made
against the RECIPIENT by any other party, due to or arising from the
use of IRE1 by the RECIPIENT, except to the extent permitted by law
when caused by the gross negligence or willful misconduct of IRE1
PROVIDER as determined by a court of competent jurisdiction.